Why does nutrient efficiency increasingly depend on making every agricultural input count more?
The future of nutrient efficiency and climate resilience will not be defined by adding more inputs, but by making every input count for more. Ag Biotech has built its operating model around that premise.
Founded in 1992 as a regional agricultural retailer in upstate New York, the company worked directly with orchard producers and distributors and saw how cost, logistics and seasonal variability shaped what could realistically be used in the field. Many high-volume inputs fell short not because they lacked efficacy, but because they were difficult to transport, store and apply consistently.
Those realities shaped a clear design principle. Crop inputs must deliver agronomic performance while remaining compact enough to move, store and apply efficiently across different farming environments.
Today, Ag Biotech delivers ultra-concentrated biological crop inputs engineered to operate at a fraction of conventional application rates. The same formulations serve large commercial operations and smallholder farms in remote regions without reformulation.
How do ultra-concentrated biological inputs improve nutrient efficiency while reducing fertilizer dependence?
That approach is embodied in the company’s core portfolio, led by the biostimulant BioShot and the biofertilizer BioSeeded. Rather than relying on volume to offset stress, the formulations work through plant metabolism and soil microbiology, activating the pathways that govern how nutrients are converted into yield. In field trials, including rice trials in the Philippines, growers reduced synthetic nitrogen use by up to 25 percent while maintaining or improving yields.
“Our products allow us to have a real impact on the economics, agronomics and livelihoods of farmers,” says Tristan Hudak, director of international development.
That farmer-first orientation continues to guide product development and international expansion.
Engineering Efficiency into Plant and Soil Systems
How do plant metabolism regulators and microbial consortia work together to boost yield?
BioShot applies the concentration-driven model at the plant level. Used at approximately two ounces per acre, or about 150 milliliters per hectare, it combines patented brassinosteroids and tricontanol to regulate photosynthesis and plant respiration during critical growth stages.
This regulation supports the accumulation of osmolytes and simple sugars, strengthening tolerance to heat, drought and cold while improving nutrient uptake.
BioSeeded extends biological performance into the soil environment. Formulated as a stable consortium of four bacterial strains and one fungal strain, the biofertilizer mobilizes nitrogen, phosphorus and potassium from soil reserves and applied fertilizers.
Designed for durability, it remains shelf-stable for up to two years and integrates across seed treatment, in-furrow application, fertigation and transplant dips.
Used together, the products function as a coordinated system. BioShot enhances carbon availability in the rhizosphere, supporting microbial activity, while BioSeeded improves nutrient access and uptake across the growing cycle.
Proven Performance at Scale
What real-world yield gains and sustainability outcomes emerge from concentrated biological inputs?
Ag Biotech’s technologies are deployed across Central America, East Africa and Southeast Asia, regions where climate-driven abiotic stress and limited access to bulk fertilizers place sustained pressure on productivity. These environments reflect the operating conditions the company designs for.
That focus translated into measurable outcomes through Ag Biotech’s participation in the AIM for Climate Innovation Sprint between 2024 and 2025. The company supported the adoption by more than 80,000 smallholder farmers, trained 170 agricultural extension agents and recorded yield increases of up to 134 percent under extreme abiotic stress.
Sustaining this performance is supported by a research and validation ecosystem that includes U.S. land-grant universities, international research institutions such as the Philippine Rice Research Institute, academic partners in Mexico and multiple contract research organizations. Through this pipeline, Ag Biotech is advancing its first microbial biocontrol product, planned for release in 2028, addressing a crop protection challenge exceeding $150 million annually in the U.S.
Reducing dependence on synthetic fertilizers, improving nutrient-use efficiency and lowering nitrogen-related emissions, Ag Biotech aligns product deployment with the United Nations Sustainable Development Goals.
Anchored in verified agronomic performance and farmer outcomes, Ag Biotech is building an input model designed for agricultural systems facing tighter resource constraints and rising climate pressure.
The future of nutrient efficiency and climate resilience will not be defined by adding more inputs, but by making every input count for more. Ag Biotech has built its operating model around that premise.
Founded in 1992 as a regional agricultural retailer in upstate New York, the company worked directly with orchard producers and distributors and saw how cost, logistics and seasonal variability shaped what could realistically be used in the field. Many high-volume inputs fell short not because they lacked efficacy, but because they were difficult to transport, store and apply consistently.
Those realities shaped a clear design principle. Crop inputs must deliver agronomic performance while remaining compact enough to move, store and apply efficiently across different farming environments.
Today, Ag Biotech delivers ultra-concentrated biological crop inputs engineered to operate at a fraction of conventional application rates. The same formulations serve large commercial operations and smallholder farms in remote regions without reformulation.
How do ultra-concentrated biological inputs improve nutrient efficiency while reducing fertilizer dependence?
That approach is embodied in the company’s core portfolio, led by the biostimulant BioShot and the biofertilizer BioSeeded. Rather than relying on volume to offset stress, the formulations work through plant metabolism and soil microbiology, activating the pathways that govern how nutrients are converted into yield. In field trials, including rice trials in the Philippines, growers reduced synthetic nitrogen use by up to 25 percent while maintaining or improving yields.
“Our products allow us to have a real impact on the economics, agronomics and livelihoods of farmers,” says Tristan Hudak, director of international development.
That farmer-first orientation continues to guide product development and international expansion.
Engineering Efficiency into Plant and Soil Systems
How do plant metabolism regulators and microbial consortia work together to boost yield?
BioShot applies the concentration-driven model at the plant level. Used at approximately two ounces per acre, or about 150 milliliters per hectare, it combines patented brassinosteroids and tricontanol to regulate photosynthesis and plant respiration during critical growth stages.
This regulation supports the accumulation of osmolytes and simple sugars, strengthening tolerance to heat, drought and cold while improving nutrient uptake.
-
Our products allow us to have a real impact on the economics, agronomics and livelihoods of farmers.
BioSeeded extends biological performance into the soil environment. Formulated as a stable consortium of four bacterial strains and one fungal strain, the biofertilizer mobilizes nitrogen, phosphorus and potassium from soil reserves and applied fertilizers.
Designed for durability, it remains shelf-stable for up to two years and integrates across seed treatment, in-furrow application, fertigation and transplant dips.
Used together, the products function as a coordinated system. BioShot enhances carbon availability in the rhizosphere, supporting microbial activity, while BioSeeded improves nutrient access and uptake across the growing cycle.
Proven Performance at Scale
What real-world yield gains and sustainability outcomes emerge from concentrated biological inputs?
Ag Biotech’s technologies are deployed across Central America, East Africa and Southeast Asia, regions where climate-driven abiotic stress and limited access to bulk fertilizers place sustained pressure on productivity. These environments reflect the operating conditions the company designs for.
That focus translated into measurable outcomes through Ag Biotech’s participation in the AIM for Climate Innovation Sprint between 2024 and 2025. The company supported the adoption by more than 80,000 smallholder farmers, trained 170 agricultural extension agents and recorded yield increases of up to 134 percent under extreme abiotic stress.
Sustaining this performance is supported by a research and validation ecosystem that includes U.S. land-grant universities, international research institutions such as the Philippine Rice Research Institute, academic partners in Mexico and multiple contract research organizations. Through this pipeline, Ag Biotech is advancing its first microbial biocontrol product, planned for release in 2028, addressing a crop protection challenge exceeding $150 million annually in the U.S.
Reducing dependence on synthetic fertilizers, improving nutrient-use efficiency and lowering nitrogen-related emissions, Ag Biotech aligns product deployment with the United Nations Sustainable Development Goals.
Anchored in verified agronomic performance and farmer outcomes, Ag Biotech is building an input model designed for agricultural systems facing tighter resource constraints and rising climate pressure.
Company : Ag Biotech
Headquarters :
. ManagementRobert Hudak CEO and Tristan Hudak, Director of International Development
Thank you for Subscribing to Agri Business Review Weekly Brief
